The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 43-52

  Pitman, Wendy A ^a   Osgood, Doreen P ^a   Smith, Donald ^a   Schaefer, Ernst J ^a   Ordovas, José M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Diet; Hamsters; HMG CoA reductase inhibitors; HMG CoA reductase mRNA levels; LDL receptor mRNA levels

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MEVINOLIN;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; DRUG EFFECT; ENZYME INHIBITION; FOAM CELL; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; CRICETINAE; DIET; DIET, ATHEROGENIC; DIETARY FATS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTESTINES; LIVER; LOVASTATIN; MALE; RECEPTORS, LDL; RNA, MESSENGER;

EID: 0032076231     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00302-X     Document Type: Article

References (36)

1. Nistor A., Bulla A., Filip D.A., Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis. 68:1987;159-173.
2. Kowala M.C., Nunnari J.J., Durham S.K., Nicolosi R.J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis. 91:1991;35-49.
3. Foxall T.L., Shwaery G.T., Stucchi A.F., Nicolosi R.J., Wong S.S. Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model. Am J Pathol. 140:1992;1357-1363.
4. Otto J., Ordovas J.M., Smith D., Van Dongen D., Nicolosi R.J., Schaefer E.J. Lovastatin inhibits diet induced atherosclerosis in F1B Golden Syrian hamsters. Atherosclerosis. 114:1995;19-28.
5. Ma P.T.S., Gil G., Sudhof T.C., Bilheimer D.W., Goldstein J.L., Brown M.S. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA. 83:1986;8370-8374.
6. McNamara J.R., Schaefer E.J. Automated enzymatic standardized lipid analyses for plasma and apolipoprotein fractions. Clin Chim Acta. 166:1987;1-9.
7. Amin D., Gustafson S., Perrone M.H. Lovastatin is hypertriglyceridemic in Syrian Golden hamsters. Biochem Biophys Res Comm. 157:1988;530-534.
8. Himber J., Missano B., Rudling M., Hennes U., Kempen H.J. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets. J Lipid Res. 36:1995;1567-1585.
9. Sinzinger H., Mayr F., Schmid P., Granegger S., O'Grady J., Peskar B.A. Sleep disturbance and appetite loss after lovastatin. Lancet. 343:1994;973.
10. Horton J.D., Cuthbert J.A., Spady D.K. Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels. J Clin Invest. 92:1993;743-749.
11. Blankenhorn D.H., Azen S.P., Kramsch D.M., Mack W.J., Cashin-Hemphill L., Hodis H.N., DeBoer L.W.V., Mahrer P.R., Masteller M.J., Vailas L.I., Alaupovic P., Hirsch L.J. MARS Research Group. Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med. 119:1993;969-976.
12. Goulinet S., Chapman M.J. Plasma lipoproteins in the Golden Syrian hamster (Mesocricetus auratus): Heterogeneity of apoB- and apoA-I-containing particles. J Lipid Res. 34:1993;943-959.
13. Stein Y., Dabach Y., Hollander G., Stein O. Cholesteryl ester transfer activity in hamster plasma: increase by fat and cholesterol rich diets. Biochim Biophys Acta. 1042:1990;138-141.
14. Singhal A.K., Finver-Sadowsky J., McSherry C.K., Mosbach E.H. Effect of cholesterol and bile acids on the regulation of cholesterol metabolism in hamster. Biochim Biophys Acta. 752:1983;214-222.
15. Surette M.E., Whelan J., Lu G.-P. Broughton KS, Kinsella JE. Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster. J Lipid Res. 33:1992;263-271.
16. Robins S.J., Fasulo J.M., Patton G.M., Schaefer E.J., Smith D.E., Ordovas J.M. Gender differences in the development of hyperlipemia and atherosclerosis in hybrid hamsters. Metabolism. 44:1995;1326-1331.
17. Sullivan M.P., Cerda J.J., Robbins F.L., Burgin C.W., Beatty R.J. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab Anim Sci. 43:1993;575-578.
18. Spady D.K., Dietschy J.M. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest. 81:1988;300-309.
19. Spady D.K., Dietschy J.M. Interaction of aging and dietary fat in the regulation of low density lipoprotein transport in the hamster. J Lipid Res. 30:1989;559-569.
20. Woollett L.A., Spady D.K., Dietschy J.M. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentrations in hamsters. Differential effects of fatty acid chain length. J Clin Invest. 84:1989;119-128.
21. Woollett L.A., Spady D.K., Dietschy J.M. Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. J Clin Invest. 89:1992;1133-1141.
22. Spady D.K., Dietschy J.M. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc Natl Acad Sci USA. 82:1985;4526-4530.
23. Woollett L.A., Spady D.K., Dietschy J.M. Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res. 33:1992;77-88.
24. La Ville A.E., Seddon A.M., Shaikh M., Rowles P.M., Woolf N., Lewis B. Primary prevention of atherosclerosis by lovastatin in a genetically hyperlipidaemic rabbit strain. Atherosclerosis. 78:1989;205-210.
25. Kobayashi M., Ishida F., Takahashi T., Taguchi K., Watanabe K., Ohmura I., Kamei T. Preventive effect of MK-733 (simvastatin), an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits. Jpn J Pharmacol. 49:1989;125-133.
26. Hadjiisky P., Hermier D., Truffert J., De Gennes J.-L., Grosgogeat Y. Effect of pravastatin, a HMG CoA reductase inhibitor, on blood lipids and aortic lipidosis in cholesterol-fed White Carneau pigeons. Biochim Biophys Acta Mol Basis Dis. 1181:1993;279-286.
27. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C., Liu C., Alaupovic P., Kwong Fu.-H., Azen S.P. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med. 124(6):1996;548-556.
28. Zhu B.Q., Sievers R.E., Sun Y.P., Isenberg W.M., Parmley W.W. Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J Cardiovasc Pharmacol. 19(2):1992;246-255.
29. Goldstein J.L., Brown M.S. Progress in understanding the Low density lipoprotein receptor and HMG-CoA reductase, two proteins that regulate the plasma cholesterol. J Lipid Res. 25:1984;1450-1461.
30. Spady D.K., Turley S.D., Dietschy J.M. Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. J Lipid Res. 26:1985;465-472.
31. Rudling M. Hepatic mRNA levels for the low density lipoprotein receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res. 33:1992;493-501.
32. Ma P.T., Yamamoto T., Goldstein J.L., Brown M.S. Increased mRNA for low density lipoprotein receptor in livers and rabbits treated with 17-ethinyl estradiol. Proc Natl Acad Sci USA. 83:1986;792-796.
33. Trautwein E.A., Liang J., Hayes K.C. Plasma lipoproteins, biliary lipids and bile acid profile differ in various strains of Syrian hamsters Mesocricetus auratus. Comp Biochem Physiol A. 104A:1993;829-835.
34. Trautwein E.A., Liang J., Hayes K.C. Cholesterol gallstone induction in hamsters reflects strain differences in plasma lipoproteins and bile acid profiles. Lipids. 28:1993;305-312.
35. Owen C.H., Sorci-Thomas M., Rudel L.L. Dietary fat and cholesterol-induced modification of LDL receptor function and mRNA abundance in nonhuman primates (Abstract). Arterioscler Thromb. 11:1991;1447a.
36. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.